Photo courtesy of Lunit
Lunit to supply breast imaging AI in France
South Korean medical AI company Lunit has secured a four-year deal that makes its AI-powered breast imaging software available to more than 1,500 public hospitals across France.
The agreement with the French procurement network UniHA lists Lunit's AI-powered mammography and digital breast tomosynthesis products as approved options via primary contractor Fujifilm for adoption without running individual tenders.
According to UniHA, which coordinates centralised purchasing for over 130 regional hospital groups, the contract ensures fair access to advanced technologies in the public hospital sector.
Vuno divests bone age AI business
Another Korean company in medical imaging AI, Vuno, has sold its business and technology related to its AI-powered bone age analysis solution to local AI platform firm MyHub.
In a statement, the company said the 2.7 billion won (US$2 million) sale is part of a strategy to focus on core growth areas, particularly biosignal-based AI and preventive medicine. Vuno intends to concentrate on scaling its flagship product, an AI-enabled cardiac arrest prediction tool, after its restructuring.
The move follows the sale of its lung disease diagnosis AI technology in Japan to competitor Coreline Soft earlier this year. That deal, paired with a $2.3 million investment in Coreline, also marked the latter's entry into the Japanese market.
AIIMS Delhi unveils AI-based mental health app
The All India Institute of Medical Science, New Delhi, in India has introduced a new mobile-based mental health and wellness programme powered by AI.
The Never Alone app on WhatsApp provides mental health screening, intervention, and follow-up support. It can help identify and address suicidal tendencies among students, according to the university.
The app has also been made available at AIIMS Bhubaneswar and the Institute of Human Behaviour and Allied Sciences in Shahdara.
